JP Morgan Maintains Overweight on Tenet Healthcare, Raises Price Target to $140
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Lisa Gill maintains an Overweight rating on Tenet Healthcare (NYSE:THC) and raises the price target from $107 to $140.
May 30, 2024 | 6:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JP Morgan analyst Lisa Gill maintains an Overweight rating on Tenet Healthcare and raises the price target from $107 to $140.
The raised price target from $107 to $140 by a reputable analyst at JP Morgan is likely to positively impact Tenet Healthcare's stock price in the short term. The Overweight rating suggests strong confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100